Total Payments
$2,924
2024 Payments
$1,918
Companies
17
Transactions
164
Medicare Patients
725
Medicare Billing
$49,215
Payment Breakdown by Category
Food & Beverage$2,924 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,924 | 164 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $757.81 | 36 | $0 (2024) |
| Janssen Biotech, Inc. | $457.88 | 29 | $0 (2024) |
| ABBVIE INC. | $340.25 | 35 | $0 (2024) |
| QOL Medical, LLC | $222.33 | 7 | $0 (2024) |
| GENZYME CORPORATION | $202.46 | 10 | $0 (2024) |
| Lilly USA, LLC | $176.70 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $163.55 | 9 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $161.94 | 5 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $98.55 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $72.25 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,918 | 116 | Takeda Pharmaceuticals U.S.A., Inc. ($443.49) |
| 2023 | $831.11 | 41 | Takeda Pharmaceuticals U.S.A., Inc. ($232.24) |
| 2022 | $92.36 | 6 | Janssen Biotech, Inc. ($25.45) |
| 2021 | $82.08 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($82.08) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Immunology | ||||||
| 11/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: GI | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 171 | 175 | $25,968 | $10,048 |
| 2022 | 5 | 235 | 261 | $51,851 | $16,906 |
| 2021 | 3 | 204 | 235 | $40,270 | $16,309 |
| 2020 | 5 | 115 | 120 | $17,879 | $5,953 |
Total Patients
725
Total Services
791
Medicare Billing
$49,215
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $8,210 | $2,685 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $2,893 | $1,628 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 34 | 35 | $2,340 | $1,447 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 32 | $4,020 | $1,291 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,148 | $1,215 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 13 | $1,253 | $818.48 | 65.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 15 | 15 | $1,619 | $779.54 | 48.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 11 | 11 | $485.00 | $182.88 | 37.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 60 | 60 | $15,420 | $5,217 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 107 | $14,445 | $5,177 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $14,168 | $3,895 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 33 | $6,468 | $2,286 | 35.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,350 | $330.53 | 24.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 121 | $14,520 | $6,551 | 45.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 58 | 58 | $15,950 | $5,416 | 34.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 56 | $9,800 | $4,342 | 44.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $4,125 | $1,278 | 31.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 19 | $3,325 | $1,108 | 33.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 26 | $3,120 | $1,077 | 34.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 21 | $2,268 | $945.45 | 41.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 25 | 28 | $2,016 | $777.97 | 38.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 11 | 11 | $3,025 | $765.49 | 25.3% |
About Erin Cade
Erin Cade is a Physician Assistant healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2019. The National Provider Identifier (NPI) number assigned to this provider is 1578128575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erin Cade has received a total of $2,924 in payments from pharmaceutical and medical device companies, with $1,918 received in 2024. These payments were reported across 164 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,924).
As a Medicare-enrolled provider, Cade has provided services to 725 Medicare beneficiaries, totaling 791 services with total Medicare billing of $49,215. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Fort Wayne, IN
- Active Since 05/06/2019
- Last Updated 10/12/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1578128575
Products in Payments
- ENTYVIO (Biological) $526.90
- DUPIXENT (Biological) $366.01
- STELARA (Biological) $265.89
- SUCRAID (Drug) $222.33
- ZENPEP (Drug) $161.94
- LINZESS (Drug) $128.84
- OMVOH (Drug) $112.41
- REMICADE (Biological) $109.66
- EOHILIA (Drug) $107.80
- GATTEX (Drug) $102.14
- Linzess (Drug) $98.55
- SKYRIZI (Biological) $85.14
- TREMFYA (Drug) $82.33
- DIFICID (Drug) $72.25
- VOQUEZNA (Drug) $67.04
- RINVOQ (Biological) $58.36
- XIFAXAN (Drug) $52.01
- IBSRELA (Drug) $43.05
- CREON (Drug) $36.35
- RUCONEST (Biological) $34.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Fort Wayne
A. Ferguson, Pa-C, PA-C
Physician Assistant — Payments: $17,525
Physician Assistant $17,525
Guinevere Nilles, Pa, PA
Physician Assistant — Payments: $11,751
Physician Assistant $11,751
Stephen Grote, Pa-C, PA-C
Physician Assistant — Payments: $11,375
Physician Assistant $11,375
Dana Lingel, Pa-C, PA-C
Physician Assistant — Payments: $9,784
Physician Assistant $9,784
Kristi Brennan, Pa-C, PA-C
Physician Assistant — Payments: $5,919
Physician Assistant $5,919
Jason Gaisford, Pa-C, PA-C
Physician Assistant — Payments: $5,129
Physician Assistant $5,129